Galena Biopharma Receives 2013 Global Frost & Sullivan Award for New Product Innovation for NeuVax(TM)

Galena Biopharma Receives 2013 Global Frost & Sullivan Award for New Product Innovation for NeuVax(TM)

[at noodls] – LAKE OSWEGO, Ore., March 14, 2013 (GLOBE NEWSWIRE) — Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical needs … more

View todays social media effects on GALE

View the latest stocks trending across Twitter. Click to view dashboard

See who Galena is hiring next, click here to view

Share this post